Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tPA and DNase vs Medical Thoracoscopy for Pleural Infection
NCT03468933Phase 4Completed
- Sponsor
- Tulane University
- Start
- Nov 2017
- Primary completion
- Dec 2019
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator, dornase alfa in pleural infection, empyema, parapneumonic effusion, sponsored by Tulane University. Started Nov 2017; status: completed.
02
Drugs
tissue-plasminogen activatordornase alfa
03
Conditions
pleural infectionempyemaparapneumonic effusion
Beyond the preview
Go deeper on NCT03468933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03468933.